Congress Must Protect CFPB From Financial Predators’ Push to Silence Agency
April 26, 2023 — In response to a legislative markup session for the the Consumer Financial Protection Bureau (CFPB) Transparency and Accountability Reform Act, legislation that includes the Taking Account of Bureaucrats’ Spending (TABS) Act, the American Economic Liberties Project released the following statement.
New Policy Brief Reveals High Cost of Hospital Consolidation and How Policymakers Can Fight Back
April 26, 2023 — The American Economic Liberties Project today released "The Harms of Hospital Mergers and How to Stop Them,” a new policy brief that details how hospital mergers hurt patients and staff, and offers a policy roadmap for federal and state to push back against the rapid consolidation sweeping the industry.
Democrats and Republicans Take Important Steps To Safeguard America’s Prescription Drug Markets From Pharmacy Benefit Managers
April 20, 2023 — Members of Congress across the political spectrum are stepping up to curtail the deleterious effects that pharmacy benefit managers (PBMs) have on our prescription drug markets.
Economic Liberties Supports FTC’s Noncompete Ban and Dismantles Corporate Criticism
April 19, 2023 — The American Economic Liberties Project today submitted written comments to the Federal Trade Commission in response to the agency’s Notice of Proposed Rulemaking to ban restrictive noncompete clauses.
Advocates Urge FTC to Investigate Energizer-Rayovac Merger Amid Growing Outsourcing Concerns
April 17, 2023 — Amid reports of price increases and job outsourcing, the American Economic Liberties Project and nine other organizations today sent a letter urging the Federal Trade Commission to open an investigation into Energizer’s 2018 acquisition of Rayovac and evaluate whether a divestiture is needed.